Vision and strategy of zahravi’s R&D department

At zahravi our goal is designed in according to produce new pharmaceutical products and amend the formulation with respect to GMP & GLP, stabilizing the drug substances, determination of degradation products in products by utilizing the GC, HPLC, capillary electrophoresis, potentiometric and ‏TLC methods. All methods are developed to quantitate the level of degradation substances.

The performance of all methods are evaluated with respect to specificity, system precision, linearity and limit of detection.

Total area for R&D department is 636 m²surrounding the following labs:

a) Research and development of dosage forms

Containing all necessary requirements for liquid and solid forms. Two stability chambers are located in this section for implementing periodic and accelerated stability tests.

b) Microbiology lab

The validation of microbial limit tests for all products and applying the bioassay tests, performance of cleaning validation are being developed in this section.

C) Physic & ch emi stry section.

For implementing physical and chemical analysis according to pharmacopoeias and advanced analytical methods.

The experts working in R&D department carry on the formulation of new products applying the following procedures.

A) Planning

B) Design

C) Draft

D) Design put

E) Design output

F) Design review

G) Design verification

H) Design changes.

Ethical principles

R&D personnels undertake their responsibilities to establish GMP and GLP and perform own activities to improve the qualification of products in the aim of approaching the healthy of societies.

The education of R&D experts are continiously and systematically being enhanced according to regular curriculum.

They also connect to international websites and are in communication with

the best universities, Ministry of health and the other society of scientists relating to pharmaceutical matters.